Medicare Enrolled

Dr. Scott Burlison, MD

Pain Medicine · Tyler, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3414 GOLDEN RD, Tyler, TX 75701
9039397500
In practice since 2007 (18 years)
NPI: 1932303534 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Burlison from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Burlison? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Burlison

Dr. Scott Burlison is a pain medicine in Tyler, TX, with 18 years in practice. Based on federal Medicare data, Dr. Burlison performed 3,734 Medicare services across 1,767 unique beneficiaries.

Between the years covered by Open Payments, Dr. Burlison received a total of $2,957 from 13 pharmaceutical and/or device companies across 46 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Burlison is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 29% volume in TX$ $2,957 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,734
Medicare services
Top 29% in TX for pain medicine
1,767
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~207 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Chronic care management, first 20 min/month1,042$44$129
Office visit, established patient (30-39 min)822$88$338
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level333$98$1,081
Dexamethasone injection (steroid)221$0$10
New patient office visit (45-59 min)202$118$510
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level154$39$351
Injection, ketorolac tromethamine, per 15 mg112$0$20
Chronic care management, additional 20 min/month106$36$65
Injection of trigger points, 1-2 muscles96$39$175
X-ray of lower and sacral spine, 2-3 views92$30$118
Injection of substance into middle or upper spine canal using imaging guidance86$75$813
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint49$51$589
Injection of lower or sacral spine facet joint using imaging guidance, single level40$81$919
Injection of lower or sacral spine facet joint using imaging guidance, second level38$48$471
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint38$45$537
Injection of contrast for imaging of hip under anesthesia30$65$1,106
X-ray of upper spine, 2-3 views29$30$118
Review by radiologist of hip joint image29$21$383
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance28$75$746
Injection of upper or middle spine facet joint using imaging guidance, single level27$102$975
Injection of upper or middle spine facet joint using imaging guidance, second level27$58$489
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint25$145$1,317
Joint injection, major joint24$53$245
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint24$124$1,303
X-ray of middle spine, 2 views24$8$98
X-ray of knee, 1-2 views20$6$103
Destruction of nerves supplying joint between spine and pelvis using imaging guidance16$148$1,560
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,957
Total received (2018-2024)
Avg $422/year across 7 years
Bottom 49% in TX for pain medicine
13
Companies
46
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,957 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$861
2023
$23
2022
$29
2021
$122
2020
$733
2019
$669
2018
$519

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$1,762
Abbott Laboratories
$343
Medtronic, Inc.
$207
Stimwave Technologies Incorporated
$184
BIOTRONIK NRO, Inc.
$142
Stryker Corporation
$105
Nalu Medical, Inc.
$69
BOSTON SCIENTIFIC CORPORATION
$59
Amgen Inc.
$25
Saluda Medical Americas, Inc.
$23
Flexion Therapeutics, Inc.
$16
Boston Scientific Corporation
$11
Ferring Pharmaceuticals Inc.
$11
Top 3 companies account for 78.2% of total payments
Associated products mentioned in payments ›
ETERNA · EUFLEXXA · EVENITY · Evoke SCS · GENERAL PAIN MANAGEMENT · INTELLIS ADAPTIVESTIM · MAKO · Nalu Neurostimulation System · Octrode SCS Leads · Omnia · Proclaim Family of SCS IPGs · Prospera · SCS IPGs · Senza · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $79 per 100 Medicare services performed
Looking for a pain medicine in Tyler?
Compare pain medicines in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain Medicines within 10 mi
3
Per 100K population
1.3
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Burlison is a clinical cardiology specialist, with above-average Medicare volume (top 29% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Burlison experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Burlison performed 1,042 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Burlison receive payments from pharmaceutical companies?
Yes. Dr. Burlison received a total of $2,957 from 13 companies across 46 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Burlison's costs compare to other pain medicines in Tyler?
Dr. Burlison's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Burlison) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →